Investor Relations

(Security Code :4506 TSE Prime)

Pick Up

Apr. 27, 2026	Notice regarding Withdrawal of Shelf Registration Statement for Issuance of New Shares	Finances
Apr. 20, 2026	Notice Regarding Determination of Issue Price, Selling Price and Other Matters	Finances
Apr. 08, 2026	Notice Regarding Issuance of New Shares and Secondary Offering of Shares	Finances
Apr. 08, 2026	Notice Regarding Refinancing of Existing Borrowings through a Bridge Loan	Finances
Mar. 30, 2026	Sumitomo Pharma Submits Partial Change Application in Japan to Add Pediatric Dosage and Administration for LATUDA in Schizophrenia	R&D
Mar. 25, 2026	Notice Concerning Non-operating Income Recorded in the Company’s Non-consolidated Financial Statements (Japanese GAAP)	Finances

May 13, 2026	FY2025 financial results announcement (scheduled to be disclosed at 1:00 p.m.), conference on financial results FY2025 for Analysts, Investors, and the Press